Results 281 to 290 of about 14,050 (297)

Extended Duration of Impella 5.5 Support Does Not Adversely Impact Outcomes Following Heart Transplantation: A National Registry Analysis

ASAIO journal (1992)
Prior studies assessing the effects of Impella 5.5 support duration on posttransplant outcomes have been limited to single-center case reports and series.
Yeahwa Hong, A. Dorken-Gallastegi, Umar Nasim, N. Hess, Luke A. Ziegler, M. Abdullah, N. Iyanna, Raj Ramanan, Gavin W Hickey, D. Kaczorowski   +9 more
semanticscholar   +1 more source

Impella removal with access site salvage

Catheterization and Cardiovascular Interventions, 2018
AbstractRemoval of the percutaneous Impella CP assist device while maintaining femoral artery access site is not always possible. This case highlights a technique of Impella removal with access site salvage.
Neil Yager, Sergio Waxman
openaire   +3 more sources

Standardization of Impella®-assisted patient management

Minerva Cardioangiologica, 2018
The presence of high-risk features on candidates to percutaneous revascularization is increasingly leading to Impella®-assisted procedures (IAPs). While IAPs are safe and effective procedures, they still require managing a degree of complexity. Clinicians often rely on their ability to recall every step of operative procedures.
Tommaso Sanna, Ilaria Battistoni, Serafina Valente, Marco Marini   +3 more
openaire   +3 more sources

Trajectories following Impella 5.5 support are associated with initial presentation acuity

Artificial Organs
Background Impella 5.5 is a temporary left ventricular assist device utilized to support patients with cardiogenic shock and those undergoing high‐risk cardiac interventions.
Jean-Luc A. Maigrot, Randall C. Starling, E. Soltesz, Nicholas G. Smedira, M. Tong, S. Unai, Pavan Bhat, David Moros, Eugene Blackstone, Aaron J. Weiss   +9 more
semanticscholar   +1 more source

Die chirurgisch implantierte Impella

2020
Die chirurgisch implantierte Impella hat in den letzten Jahren erheblich an Bedeutung gewonnen und wurde in zunehmendem Mase in Deutschland und weltweit implantiert. Initial entwickelt, femoral oder direkt aortal implantiert zu werden, werden die chirurgisch implantierten Impella-Gerate mittlerweile fast ausschlieslich axillar implantiert.
openaire   +2 more sources

Bridging with surgical implanted Impella devices

European Journal of Cardio-Thoracic Surgery, 2023
Alexander M Bernhardt, Hermann Reichenspurner   +1 more
openaire   +2 more sources

Rapid exchange of an Impella 5.0. for an Impella 5.5 through the same arterial axillary access

Artificial Organs, 2021
Willem te Gussinklo, Sameer Al‐Maisary
openaire   +2 more sources

Impella Malrotation Within the Left Ventricle Is Associated With Adverse In-Hospital Outcomes in Cardiogenic Shock.

JACC: Cardiovascular Interventions, 2023
L. Baldetti, A. Beneduce, D. Romagnolo, A. Frias, M. Gramegna, S. Sacchi, F. Calvo, V. Pazzanese, A. Cappelletti, S. Ajello, A. Scandroglio, A. Chieffo   +11 more
semanticscholar   +1 more source

Left Ventricular Unloading With Impella Versus IABP in Patients With VA-ECMO: A Systematic Review and Meta-Analysis.

American Journal of Cardiology, 2023
K. Gandhi, E. Moras, Shailesh Niroula, Persio D. Lopez, Devika Aggarwal, K. Bhatia, Y. Balboul, J. Daibes, Ashish Correa, Abel Casso Dominguez, E. Birati, David A. Baran, Gregory Serrao, Kiran Mahmood, S. Vallabhajosyula, A. Fox   +15 more
semanticscholar   +1 more source

Intra-aortic balloon pump is associated with the lowest whereas Impella with the highest inpatient mortality and complications regardless of severity or hospital types.

Cardiovascular Intervention and Therapeutics
M. Movahed, Armin Talle, M. Hashemzadeh
semanticscholar   +1 more source